The MFDS (Director Kim Kang-rip) announced on the 29th that it has released 299,000 doses of Pfizer's Comirnaty 0.1mg/mL (for 5-11 years old) in Korea.

The MFDS conducted Comirnaty test and reviewed the manufacturing and test data of the manufacturer, and confirmed the effectiveness, safety, and quality, and decided to release the national lot according to the standards. Comirnaty 0.1mg/mL (for 5-11 years old) is an mRNA vaccine developed and produced by Pfizer of the United States for the purpose of preventing COVID-19 between the ages of 5 and 11. The previously approved Comirnaty, Comirnaty 0.1 mg/mL and Tozinameran were the same active ingredient, but the dose was reduced to 1/3 (10)) per inoculatio